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Background: Gait ability and cognitive function are interrelated during both normal walking (NW) and dual-task
walking (DTW), and gait ability is thus adversely affected by cognitive impairment in both situations. However, this
association is insufficiently understood in people with mild cognitive impairment (MCI). Here, we conducted a study
with MCI participants, to examine whether the association depends on walking conditions and MCI subtypes.
Methods: We classified 389 elderly adults into amnestic MCI (n = 191) and non-amnestic MCI (n = 198), assessed
their cognitive functions, and administered gait experiments under NW and DTW conditions. Gait ability was
defined as gait speed. Five aspects of cognitive function were assessed: processing speed, executive function,
working memory, verbal memory, and visual memory.
Results: Regression analysis adjusted for covariates showed a significant association between cognitive functions
and gait speed. Processing speed and executive function correlated with gait speed during both NW and DTW
(p < .05). Gait speed during DTW was also significantly associated with working memory (p < .001). Visual memory
was associated during NW and DTW, particularly for amnestic MCI participants (p < .05).
Conclusions: Our findings support the idea that the association between gait speed and cognitive function
depends on walking condition and MCI subtypes. Additional studies are necessary to determine the neural basis for
the disruption in gait control in older adults with MCI.Background
Dementia is a notable health issue because of its exten-
sive impact on the activities and quality of life of older
adults. Given the current absence of disease-modifying
treatments, as well as increasing awareness that symp-
toms develop over many years or even decades, there
has been growing interest in early detection and effective
strategies for prevention [1]. Mild cognitive impairment
(MCI) is considered a clinical characteristic that typifies
the prodromal phase of Alzheimer’s disease (AD), the
most common type of dementia [2]. Numerous studies* Correspondence: take-d@ncgg.go.jp
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unless otherwise stated.have identified a wide range of potentially modifiable
risk factors for AD and dementia, including cardiovas-
cular risk factors, psychosocial factors, and health beha-
viors [1,3]. Gait impairment is a common characteristic
in participants with cognitive impairments [4-6] and is a
risk factor for developmental MCI and dementia [7,8].
Cognition and gait are thought to be strongly linked, a
contention supported by findings from experimental
studies using a dual-task paradigm to epidemiology.
Less is known about the relationships between specific
cognitive functions and gait in people with MCI, though
population studies have been conducted in older adults
to examine this issue [9-14]. Prospective studies indicate
that lower attention/executive function [9,13] or me-
mory function [9,11] may lead to a decline in gait speed
in older adults. Alternatively, a slow gait speed predicts
deficits in the cognitive-processing speed [12] or in ex-
ecutive and memory functions [14]. Emerging evidence. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lobe function such as attention and executive function
are associated with slower gait and gait instability [15].
However, a consensus regarding the relationship bet-
ween gait variables and memory deficits in particular
has not yet been reached [9-11,14]. Mielke et al. has
suggested that inconsistencies between studies may be
partially due to variation in participant characteristics
across studies, ranging from exclusively older adults
with normal cognition to mixed participant pools that
include those with MCI or AD [14]. In addition, the
decline in cognitive function in people with MCI is not
uniform, but rather depends on MCI subtype, i.e.,
amnestic (aMCI) or non-amnestic (naMCI) [2]. Further-
more, subtypes of MCI may potentially have different
neuropathologies and courses of conversion, although
the dependency of subtypes has not reached consensus
[16-20]. Investigating cognitive function in MCI partici-
pants requires considering several cognitive function
domains as well as these MCI subtypes.
The relationship between cognitive function and gait
variables in conditions other than normal walking (NW)
is insufficiently understood in people with MCI. Ob-
serving how people walk while they perform a second-
ary attention-demanding task, i.e., a dual-task paradigm,
has been used to assess interactions between cognition
and gait. Existing population studies have been con-
ducted using both NW and dual-task paradigms with
specific conditions [21-23], and gait coordination during
dual-task walking (DTW) has been shown to be deterio-
rated [24,25] and to be associated with reduced execu-
tive function [21,22]. Although evidence is scarce, gait
variables in older adults with MCI have been shown to
be affected in both NW [6] and DTW [26]. Less focus
has been given to the association between cognitive
function and gait, and no strong conclusions can be
drawn because of small MCI sample sizes, non-compre-
hensive cognitive measurements, or experiments that
only examine NW. Thus, a large population study that
combines comprehensive cognitive assessments with
experiments that include DTW will contribute to a bet-
ter understanding of the relationship between cognitive
function and gait in people with MCI.
Untangling the relationship between early gait distur-
bances and early cognitive changes may be helpful in
identifying older adults who are at risk of mobility de-
cline, falls, and progression to dementia [15]. This study
aimed to examine the association between cognitive
function and gait speed in older people with MCI, and
to examine whether these associations differed depen-
ding on walking condition (normal or dual-task) and
subtypes of MCI. Gait ability was defined as gait speed
following the standard method used in population
studies of gait [14].Methods
Participants
The study population and data were in a cohort study. Six
hundred and forty-nine participants were selected as a po-
tential study population from a cohort study (Obu Study
of Health Promotion for the Elderly [27]) and met the fol-
lowing criteria: over 65 years old, diagnosed with MCI, no
specific medical history of cerebrovascular disease, Parkin-
son’s disease, connective tissue disease, or depression, no
severe visual or auditory impairment, no current symp-
toms of depression (Geriatric Depression Scale ≥6 [28]),
not part of other research projects, and not certified to re-
ceive support from the Japanese public long-term-care in-
surance system. As a result of recruitment, 409 responded
and after giving their written informed consent 389 people
completed the neuropsychological assessments and gait
experiments. The ethics committee of the National Center
for Geriatrics and Gerontology approved this study.MCI criteria
MCI criteria followed those established and revised by
Petersen [2], and in particular, participants satisfied the
following conditions: 1) memory complaints; 2) objective
cognitive decline; 3) intact general cognitive function; and
4) independent functioning in daily living activities. Intact
general cognitive function was defined as a Mini-Mental
State Examination score >23 [29]. Objective cognitive
decline was defined as having cognitive function more
than 1.5 standard deviations lower than normal. Normal
scores were taken from the Obu Study of Health Promo-
tion for the Elderly (OSHPE) database of healthy individ-
uals [27]. Cognitive function was also assessed in multiple
domains using the National Center for Geriatrics and
Gerontology Functional Assessment Tool [30]. Partici-
pants who suffered from cognitive decline in the memory
domain were classified as aMCI, while those who did not
were classified as naMCI.Gait measures
Participants wore the same type of appropriately sized
shoes before each experiment. Participants were in-
structed to walk on a smooth 11-m horizontal walkway
that had a 2-m buffer space at both ends for acceleration
and deceleration. The time to walk 5 m to the mid-point
of the walkway was measured, and gait speed was ex-
pressed in meters per second. Two gait experiments were
performed sequentially: NW, in which participants walked
at their preferred speed, was followed by DTW. Partici-
pants were instructed to walk while counting backward
from 100 in DTW. This type of arithmetic task is com-
monly used in DTW investigations and its effects on gait
have been confirmed in a meta-analysis [24].
Table 1 Subject characteristics
Variables M± SD
Age (years) 71.6 ± 4.9
Sex (women subjects (%)) 203 (52)
Body mass index (kg/m2) 23.4 ± 2.9
Educational history (years) 11.0 ± 2.4
TMIG (score) 12.4 ± 1.1
Life-space assessment (score) 90.2 ± 15.7
Current medications (numbers) 2.2 ± 2.0
Type of MCI (amnestic MCI (%)) 191 (49)
Status of apolipoprotein E (ε4 carrier (%)) 76 (20)
Cognitive tests
MMSE (score) 26.7 ± 1.9
SDST (score) 38.9 ± 7.4
TMT-B (s) 43.5 ± 16.7
Digit span backward (score) 5.1 ± 1.6
RAVLT-delay (score) 7.3 ± 3.4
Visual reproduction (score) 21.9 ± 8.8
Normal walking
Gait speed (m/s) 1.36 ± 0.22
Dual-task walking
Gait speed (m/s) 1.23 ± 0.32
Note: TMIG: Tokyo Metropolitan Institute of Gerontology Index of Competence.
MCI: mild cognitive impairment. SDST: Symbol Digit Substitution Task. TMT-B:
Trail Making Test Part B. RAVLT: Rey Auditory Verbal Learning Test
Values are mean ± SD or numbers (proportion).
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Cognitive function was evaluated by comprehensive
neuropsychological assessment and conducted by a well-
trained speech therapist. Processing speed was assessed
using a tablet version of the Symbol Digit Substitution
Task (SDST) [30], based on the Symbol Digit Modalities
Test [31]. The score is the number of correct answers
chosen within 90 s. Executive function was evaluated
using a tablet version of the Trail Making Test Part B
(TMT-B, 15 stimuli) [30]. We recorded the amount of
time it took to complete each task, and results were
excluded from analysis if this time was greater than 90 se-
conds. Working memory was assessed using the digit span
backward test, a subset of the Wechsler Adult Intelligence
Scale III [32]. Verbal memory was assessed using the Rey
Auditory Verbal Learning Test (RAVLT) [33]. Visual me-
mory was examined using the visual reproduction subtest
of the Wechsler Memory Scale-Revised (WMS-R) [34].
Better performance is represented by lower values in the
TMT-B and higher values in the other tests.
Other covariates
Age, sex, body mass index (weight/height2), and educa-
tional history were recorded as demographic data. Medical
conditions and current medications were recorded. Apoli-
poprotein E (APOE) genotype was assessed using geno-
mic DNA extracted from peripheral blood leukocytes
or autopsy tissues using a standard method (SRL, Inc.,
Tokyo, Japan). The genotyped data were strictly controlled
under condition of anonymity and blinded from the
clinical information. Carrying ε4 is thought to be a strong
factor related to deterioration of cognitive function in
MCI participants [35]. To assess functional capacity, we
used the Tokyo Metropolitan Institute of Gerontology
Index of Competence [36] and activity level was measured
using a life-space assessment [37].
Statistical analysis
We compared participant characteristics between MCI
subtypes (aMCI and naMCI) using an unpaired t-test for
continuous variables or a chi-square test for categorical
variables. Before examining the association between cog-
nitive functions and gait variables, we first compared
cognitive functions and gait variables between aMCI and
naMCI groups. To compare cognitive function, we used a
general linear model adjusted for age, which is thought to
be a strong covariate, and participant characteristics that
differed significantly between MCI subtypes. For gait vari-
ables, we used a repeated-measures analysis of variance
(ANOVA) (adjusted for the same variables as above) to
test for the main effects of MCI subtype (aMCI or naMCI)
and walking condition (NW or DTW). To examine
whether cognitive functions were independently asso-
ciated with gait speed, we used a multivariable regressionanalysis adjusted for age, sex, body mass index, education,
medication, life space, functional capacity, and APOE
status as potential covariates. This adjusted model is con-
ducted against gait speed under NW and DTW (model 1).
Additionally, to clarify the association between cognitive
function and gait speed under DTW, model 2 adjusted
variables using model 1 added to gait speed in NW was
conducted (model 2). All analyses were performed using
commercially available software (JMP 9.0 J for Windows;
SAS Institute Japan, Tokyo, Japan). Statistical significance
was set at p < .05.
Results
The 389 participants (52% women, mean age: 71.6 years)
were classified as either aMCI (n = 191) or naMCI (n =
198). Table 1 summarizes the demographic data including
educational history, current medication, functional capa-
city, life space, and status of APOE. The proportion of
women was significantly different between MCI groups
(aMCI: n = 79, 41%; naMCI: n = 124, 63%; p < .001), while
other demographic variables were not. Therefore, when
comparing cognitive functions between MCI groups,
we adjusted for age and sex. RAVLT scores were lower in
aMCI participants, while SDST scores were lower in
Doi et al. BMC Neurology 2014, 14:67 Page 4 of 8
http://www.biomedcentral.com/1471-2377/14/67naMCI participants (RAVLT: p < .001, SDST: p = .002). No
significant differences between groups were found for the
other cognitive functions. A repeated-measures ANOVA
adjusted for age and sex showed that gait speed was
affected by walking condition (NW vs. DTW: p = .042),
but not by MCI group (naMCI vs. aMCI: p = .301).
Simple correlation analysis showed a significant rela-
tionship between normal gait speed and all cognitive func-
tions in all MCI participants (SDST: r = .406, p < .0001;
TMT-B: r = -.375, p < .0001; digit span: r = .122, p = .0166;
RAVLT: r = .209, p < .0001; visual reproduction: r = 0.306,
p < .0001). DTW was also significantly associated with
cognitive functions in all MCI participants (SDST:
r = .395, p < .0001; TMT-B: r = -.373, p < .0001; digit span:
r = .307, p < .0001; RAVLT: r = .238, p < .0001; visual
reproduction: r = .325, p < .0001). Results from cognitive
function tests are plotted against gait speed in Figure 1
(NW) and Figure 2 (DTW). A multivariate regression ana-
lysis adjusted for potential covariates was conducted and
the results for gait variables during NW are summarized
in Table 2. During NW, gait speed was associated with
SDST scores in both MCI groups (aMCI: p = .003; naMCI:
p = .009), with visual reproduction scores in aMCI par-
ticipants (p = .037), and with TMT-B scores in naMCI
participants (p = .025). Digit span and RAVLT were not
significantly associated with gait speed during NW. Asso-
ciations with gait speed during DTW are summarized in
Table 3. Cognitive functions other than RAVLT correlatedFigure 1 Cognitive measurements and gait speed during normal walk
speed (m/s) during normal walking, grouped by MCI subtype. Lines indicatwith gait speed in DTW even adjusted for normal gait
speed in aMCI participants (all tests, p < .05), while only
digit span did so in naMCI participants (p < .001).
Discussion
The results of this study indicate positive associations
between cognitive functions and gait speed in MCI par-
ticipants. The independent associations were revealed by
a multivariate analysis adjusting for several potential
confounding factors including the status of APOE. Pro-
cessing speed and executive function correlated with gait
speed during NW and DTW. Working memory was
significantly associated with gait speed during DTW in
both subtypes of MCI participants. Visual memory was
also associated with gait speed in NW and DTW par-
ticularly in aMCI participants.
Our study showed that cognitive function in MCI par-
ticipants is correlated with gait speed, and that this asso-
ciation differs depending on walking conditions (normal
or dual-task). Indeed, some prospective studies have
touched on this inter-relationship. Gait speed during
NW has been shown to be related to cognitive decline
[12], MCI [7], and risk of dementia [8], while impaired
cognitive functions have been shown to be related to a
decline in normal gait speed [9,11,13]. The majority of
studies investigating this relationship have focused on
normal gait speed and processing speed [12] or execu-
tive function [9,13], and have confirmed the relationshiping. Scatter plots showing scores of cognitive measurements and gait
e the resulting regression line for all participants.
Figure 2 Cognitive measurements and gait speed during dual-task walking. Scatter plots showing scores of cognitive measurements and
gait speed (m/s) during dual-task walking grouped by MCI subtype. Lines indicate the resulting regression line for all participants.
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participants, McGough et al. have reported that physical
performance is associated with executive function after
adjusting for age, sex, and age-related factors in seden-
tary older adults with aMCI [38]. Here, we show that in
addition to processing speed and executive function, gait
speed during DTW is also associated with working
memory in MCI participants, even after adjusting for
normal gait speed. The effect of DTW on gait variables
[24,25] and the requirement for executive function in
older adults have been reported [21,22], and cognitive
impairment (e.g., MCI) has been shown to have an
impact on DTW performance. Montero-Odasso et al.
[26] suggested that gait speed in MCI participants isTable 2 Multivariable regression results between cognitive fu
Cognitive measures Cognitive domain
SDST Processing speed
TMT-B Executive function
Digit span backward Working memory
RAVLT-delay Verbal memory
Visual reproduction Visual memory
Note: aMCI: amnestic mild cognitive impairment. naMCI: non-amnestic mild cognitiv
Part B. RAVLT: Rey Auditory Verbal Learning Test.
Multivariable regression was adjusted for age, sex, body mass index, education, me
*p < .05. †p < .01. ‡p < .001.related to working memory ability, and that the rela-
tionship is exaggerated during DTW. Our results par-
tially agree with their study in that working memory
was correlated with gait variables during DTW but
not NW. Executive function is thought to be dominant
in prefrontal lobe function. Processing speed has been
reported to correspond to prefrontal lobe function, a
region also thought to have a role in gait control [39].
Working memory systems are believed to be dominated
and require similar neural resources in prefrontal cortex
[40], although the resources for these functions are
not fully identical. Our study supports the idea that
prefrontal lobe function is required for gait in MCI
participants.nction and gait speed during normal walking
Coefficients (SE)
aMCI naMCI Total
(n = 191) (n = 198) (n = 389)
.216 (0.002)† .202 (0.002)† .209 (0.002)‡
-.095 (0.001) -.287 (0.001)‡ -.180 (0.001)‡
.013 (0.009) .006 (0.009) .006 (0.006)
.087 (0.004) .025 (0.005) .036 (0.003)
.142 (0.002)* .066 (0.002) .111 (0.012)*
e impairment. SDST: Symbol Digit Substitution Task. TMT-B: Trail Making Test
dication use, life space, functional capacity, and apolipoprotein E status.
Table 3 Multivariable regression results between cognitive function and gait speed during dual-task walking
Coefficients (SE)





aMCI naMCI Total aMCI naMCI Total
(n = 191) (n = 198) (n = 389) (n = 191) (n = 198) (n = 389)
SDST Processing speed .349 (0.004)‡ .214 (0.003)† .269 (0.002)‡ .195 (0.003)† .093 (0.003) .134 (0.002)†
TMT-B Executive function -.203 (0.002)* -.265 (0.002)† -.237 (0.001)‡ -.148 (0.001)* -.092 (0.001) -.121 (0.001)†
Digit span backward Working memory .234 (0.015)† .214 (0.013)† .227 (0.010)‡ .226 (0.012)‡ .210 (0.009) ‡ .223 (0.007)‡
RAVLT-delay Verbal memory .174 (0.007)* .047 (0.007) .101 (0.005) .120 (0.006) .032 (0.005) .079 (0.004)
Visual reproduction Visual memory .252 (0.003)‡ .109 (0.003) .196 (0.002)‡ .166 (0.002)† .068 (0.002) .128 (0.002)†
Note: aMCI: amnestic mild cognitive impairment. naMCI: non-amnestic mild cognitive impairment. SDST: Symbol Digit Substitution Task. TMT B: Trail Making Test
Part B. RAVLT: Rey Auditory Verbal Learning Test.
Model 1: Multivariable regression was adjusted for age, sex, body mass index, education, medication use, life space, functional capacity, and apolipoprotein E
status. Model 2: adjusted for variables in model 1 and gait speed in normal walking.
*p < .05. †p < .01. ‡p < .001.
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speed differed depending on MCI subtype. To our know-
ledge, this is the first report showing that memory func-
tion requiring free recall is correlated with gait variables
specifically in aMCI participants. Although a consensus
regarding the relationship between memory function and
gait ability has not been reached in studies of healthy older
adults, our results are in line with prospective studies of
healthy older adults [9,11]. Memory function in MCI,
particularly aMCI, is a clinical signature of developing AD
[2]. However, whether or not memory function relates to
gait variables remains an open debate even when includ-
ing studies using neuroimaging [41,42]. Unlike executive
function, investigations focusing on the connection bet-
ween memory and gait ability are few, and those that
do have used variable measures of memory (e.g., verbal
memory or visual memory). We examined verbal memory
(RAVLT) and visual memory (visual reproduction subtest
of the WMS-R) separately. Gait speed during both NW
and DTW conditions correlated with visual memory func-
tions in aMCI participants, while verbal memory function
never correlated with gait speed. This result may reflect
the fact that visual memory is required for visuospatial
processing in addition to simple memory functions. In
fact, cortical thickness [43] and gray matter [41] in visual
processing regions are correlated with gait variables du-
ring NW. Further study is required to clarify the relation-
ship between memory function and gait performance.
Our study had several strengths and limitations. We
used a large cohort with a sufficient sample size. Additio-
nally, our analysis included adjustments for several poten-
tial covariates, such as the status of APOE, that affect not
only pathogenesis (e.g., Aβ aggregation or neural toxicity)
[44] but cognitive decline [35]. However, some limitations
must be noted. Because a cross-sectional design was used,
the causal relationship between cognitive function and gait
is still unclear in people with MCI. Further prospective
studies are required to address this issue. Additionally, thetype and/or difficulty of the cognitive task used for DTW
could have affected the results. While the mental tracking
task we adopted (counting backwards) is widely used, the
effects of dual tasking on gait may depend on the cogni-
tive task [24]. Hence, DTW using other types of cognitive
tasks (e.g., verbal fluency) should be investigated. Finally,
neuroimaging methods have recently been used to clarify
the cortical control of gait. Further evidence using imaging
techniques should be gathered to clarify the association
between cognitive function and gait ability under varied
conditions.
Conclusion
Successful DTW for those with MCI may require adequate
cognitive function, processing speed, executive function,
working memory and visual memory. The association
between cognitive functions and gait variables partially
depends on the MCI subtype. Gait speed in both NW and
DTW are associated with memory performance particu-
larly in MCI participants whose memory performance has
declined (aMCI) compared with those with relatively intact
memory functions (naMCI). Further studies are needed to
clarify the effects of cognitive function on gait in MCI
participants.
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